Forbes sells its pharma business to Transition
This article was originally published in Scrip
Executive Summary
Forbes Medi-Tech has sold its San Diego-based pharmaceutical business unit to Transition Therapeutics after announcing in May that it would be abandoning its in-house drug development activities.